Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
MARA · Nasdaq · United States · Finance Services
In shortMARA Holdings, Inc. is loss-making.
Financial health
Mixed
Built from five areas over the last five annual reports. Tap an area to see the figures behind it. Bank or insurer: tests that do not apply to them are left out.
| Operating marginShare of each sale left after running the business, before interest and tax. | -135.0% | 0/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | -144.6% | 0/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | -34.5% | 0/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | -133.4% | n/a |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | – | n/a |
| Years with positive free cash flow (last 5) | 0 of 5 | n/a |
Weight in the score: 20%
| Profitable years (last 5) | 2 of 5 | 40/100 |
|---|---|---|
| Years of revenue decline (last 5) | 1 of 5 | 67/100 |
| Revenue growth volatility | 1557.1% | 0/100 |
| Operating margin volatility | 263.4% | 0/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | 97.5% | 100/100 |
|---|---|---|
| EPS growth, 3-year average | – | n/a |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
5 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 159 | 118 | 388 | 656 | 907 |
| Cost of revenue | 42 | 151 | 403 | 816 | – |
| Gross profit | 117 | (34) | (15) | (159) | – |
| Research & development | – | 0.1 | 2.8 | 13 | 30 |
| Operating income | (3) | (674) | 221 | 306 | (1,224) |
| Interest expense | 1.6 | 15 | 10 | 13 | 48 |
| Pre-tax income | (4.8) | (718) | 278 | 617 | (1,368) |
| Income tax | 25 | (24) | 16 | 75 | (56) |
| Net income | (30) | (694) | 261 | 541 | (1,311) |
| Diluted EPS | −$0.30 | −$6.12 | $1.06 | $1.72 | −$3.69 |
| Diluted shares (millions) | 99 | 113 | 192 | 312 | 355 |
5 older years available with the 10-year history. Essential plan, from €8.25/month →
Not computed: the model does not apply to banks and insurers.
2/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jun 30, 2026 · Data updated Aug 6, 2026